Fennec Pharmaceuticals Inc (FENC)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current FENC market cap is 142.66M. The company's latest EPS is USD -0.5871 and P/E is -12.04.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.68M | 3.33M | 6.52M | 9.74M | 25.38M |
| Operating Income | -5.27M | -4.67M | -1.02M | -1.82M | 13.74M |
| Net Income | -6.05M | -5.44M | -1.87M | -2.68M | 12.84M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 170k | 0 | 1.54M | 21.25M |
| Operating Income | -13.01M | -17.89M | -17.22M | -22.74M | -12.77M |
| Net Income | -12.78M | -18.11M | -17.35M | -23.71M | -16.05M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.82M | 19.44M | 19.03M | 26.86M | 69.19M |
| Total Liabilities | 29.16M | 29.16M | 29.56M | 38.49M | 66.18M |
| Total Equity | -7.34M | -9.73M | -10.53M | -11.62M | 3.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.15M | 31.42M | 22.41M | 26.94M | 26.86M |
| Total Liabilities | 2.27M | 2.35M | 6.64M | 29.51M | 38.49M |
| Total Equity | 11.88M | 29.07M | 15.77M | -2.57M | -11.62M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.58M | -9.52M | -12.28M | -17.14M | 39.05M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 193k | 707k | 908k | 6.64M | -1.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.06M | -15.6M | -14.22M | -18.06M | -17.14M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -71k | 32.29M | 4.98M | 20.73M | 6.64M |
| Market Cap | 142.66M |
| Price to Earnings Ratio | -12.04 |
| Price to Sales Ratio | 9.09 |
| Price to Cash Ratio | 14.56 |
| Price to Book Ratio | -16.63 |
| Dividend Yield | - |
| Shares Outstanding | 27.33M |
| Average Volume (1 week) | 89.87k |
| Average Volume (1 Month) | 82.93k |
| 52 Week Change | -29.36% |
| 52 Week High | 11.92 |
| 52 Week Low | 5.00 |
| Spread (Intraday) | 0.89 (15.08%) |
| Company Name | Fennec Pharmaceuticals Inc |
| Address |
c/o labarge weinstein llp ottawa, ontario K2K 3G4 |
| Website | https://www.fennecpharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
